Riskpilot← Back to searchSign inGet full accessEQOLOGY AS
ASActiveOrg 895862312Mustads Vei 1A, 0283 OsloRetail sale of other food · NACE 4727Est. 20100 employees
Revenue 2024
NOK 3,2M
+83% vs 2023
EBITDA margin
72.8%
+151% vs 2023
Equity ratio
22.0%
Financial strength
Net profit 2024
NOK 4M
-75% vs 2023
| Revenue | NOK 3,2M | +83% |
| EBITDA | NOK 2,3M | +151% |
| Net profit | NOK 4M | -75% |
| Total assets | NOK 48,1M | +3% |
| Equity | NOK 10,6M | -77% |
| Employees | 0 | — |
Legal name
EQOLOGY AS
Org number
895862312
Legal form
Aksjeselskap
NACE code
4727 · Retail sale of other food
Founded
26. august 2010
Share capital
NOK 5 484 193
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Å drive handel innen helsekostmarkedet og andremarkeder som står i naturlig forbindelse med helsekostmarkedet, samt alt som hermed er forbundet, herunder å delta i andre selskap.
Address
Mustads Vei 1A, 0283 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 360 | 1 492 | 1 492 | 1 742 | 3 192 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −2 019 | −1 257 | −726 | −285 | −232 | −239 | −275 | −22 | 594 | 757 | 927 | 2 324 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −265 | −594 | −662 | −875 | −910 |
| EBIT | −2 019 | −1 257 | −726 | −285 | −232 | −239 | −275 | −286 | 0 | 95 | 52 | 1 414 |
| Net financials | −640 | −25 412 | −266 | 17 | 162 | −259 | −40 | −465 | 6 760 | 12 308 | 16 279 | 2 585 |
| Profit before tax | −2 659 | −26 669 | −992 | −269 | −70 | −498 | −315 | −751 | 6 760 | 12 403 | 16 331 | 3 999 |
| Tax | −744 | −0 | −0 | −0 | −0 | −3 474 | −63 | −69 | 1 500 | 2 107 | 11 | −0 |
| Net profit | −1 915 | −30 141 | −992 | −269 | −70 | 2 977 | −252 | −683 | 5 260 | 10 296 | 16 321 | 3 999 |
| Item | 2012 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 74 751 | 44 652 | 44 562 | 43 957 | 41 970 | 37 379 | 33 081 | 33 587 | 45 624 | 59 259 | 46 651 | 48 096 |
| Equity | 43 165 | 14 812 | 13 500 | 30 509 | 30 439 | 33 267 | 30 645 | 30 400 | 35 720 | 46 546 | 46 584 | 10 583 |
| Long-term debt | 5 145 | 0 | 5 500 | 9 487 | 9 487 | 4 112 | 545 | 0 | 0 | 1 | 0 | 37 445 |
| Short-term debt | 26 441 | 29 840 | 25 562 | 3 960 | 2 044 | 0 | 1 891 | 3 186 | 9 904 | 12 712 | 67 | 68 |
| Total debt | 31 586 | 29 840 | 31 062 | 13 448 | 11 531 | 4 112 | 2 436 | 3 186 | 9 904 | 12 713 | 67 | 37 513 |
EBITDA margin
72.8%
This company
15.8%
Market median
+361% vs market
20122024
Equity ratio
22.0%
This company
38.2%
Market median
-42% vs market
20122024
Return on equity
37.8%
This company
18.4%
Market median
+105% vs market
20122024
Net profit margin
125.3%
This company
8.1%
Market median
+1447% vs market
20122024
Asset turnover
0.07×
This company
1.12×
Market median
-94% vs market
20122024
Debt / equity
3.54×
This company
0.62×
Market median
-471% vs market
20122024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RA Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
KØ | Board of Directors | 2022 | — | — |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Ip Eqology Holdco As | Company | 99.0% | 99.0% | 2024 |
Eqology As | Company | 1.0% | 1.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Immunopharma As
EQOLOGY AS Board members of EQOLOGY AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Roar Arnstad | Chief Executive Officer | 0 companies |
| Aleksander Rognerud Hetland | Board of Directors | 0 companies |
| Kim Øien | Board of Directors | 0 companies |
| Gunnar Christian Detlie | Board of Directors | 0 companies |
| Frode Marc Bohan | Board of Directors | 0 companies |
| Knut Christian Espeseth | Chairman | 0 companies |